Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 December 2022 | Story Jóhann Thormählen | Photo Anja Aucamp
Peter Makgato
Peter Makgato showed true perseverance in coming back after being out of action for more than a year with an Achilles tendon injury. The Kovsie long jumper won a bronze medal at the South African Championships in 2022.

If it wasn’t for Peter Makgato’s UFS support system, he would have been lost to South African athletics. The road of recovery after a serious injury can be lonesome, but he was never alone.

The promising long jumper had to learn to walk again after the injury to his Achilles tendon and could only compete more than a year after his dreams were shattered in November 2020.

Only months after returning to jumping in 2022, he was winning medals again.

Keeping me focused

“Without KovsieSport, I believe I would have hung up my spikes after that injury,” says Makgato. “Throughout the entire journey back, I had support from my coach (Emmarie Prinsloo; Head of KovsieSport Jumping Academy) and Oom DB (Prinsloo; Head of Athletics at KovsieSport).”

He also praises “the expert medical help” from Kovsie Health and says he went through nothing alone. “My progress was monitored by a team that knew me before the injury and this meant they were able to keep me focused on the progress and not on the injury.”

Although he had injuries before, Makgato says the emotional challenges were much bigger. “What really helped me were a few words from Wayde van Niekerk days after my operation when I went back to the track on crutches. He told me not to lose my head.

“That is the best advice you can give someone in my position. Physically I was broken, I had to make sure that mentally I fought to stay above the waters.”

Bigger goals in mind

He was only able to walk again from May 2021, started rehab in August 2021, and was running properly by December 2021.

He was only able to jump competitively again in March 2022, and a month later claimed a bronze medal at the South African Championships (7,47 m). This was followed by a USSA bronze in May 2022 (7,46 m).

“I had bigger goals in mind. Now that I look back, I realise that for a person who could not even run properly five months before and who had little preparation time, I was doing pretty good.”

And now the Master of Laws student has his sights on bigger things again: The World Athletics Championships next year and the Olympic Games in 2024.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept